Clinical Research Directory
Browse clinical research sites, groups, and studies.
Helicobacter Pylori Eradication and Follow-up
Sponsor: Shanghai Zhongshan Hospital
Summary
This randomized controlled clinical trial will estimate the eradication efficacy of different therapy for Helicobacter pylori treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.
Official title: Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
4447
Start Date
2021-09-30
Completion Date
2026-06-30
Last Updated
2021-09-30
Healthy Volunteers
No
Conditions
Interventions
Rabeprazole
20mg bid
Bismuth potassium citrate
0.6g bid
Metronidazole
0.4g qid
Clarithromycin
0.5g bid
Levofloxacin
0.5g qd
Amoxicillin
1g tid
Metronidazole
0.4g tid
Doxycycline
0.1g bid
Tetracycline
0.5g qid
Locations (1)
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China